/Investor DB

Exor Seeds — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

Vivodynevivodyne.comin𝕏Series A · May 2025 · $40M

Vivodyne is a bio-AI company that develops lab-grown human tissues and robotic systems to generate causal biological data for therapeutic development.

AI & Machine LearningBiotechDeep TechBrisbane, US

Andrei Georgescu(Executive Officer, Director)inDongeun Huh(Executive Officer, Director)Andrei Georgescu, Ph.D.(Founder)in

BoardQuinten Stevens(Director)Alex Andrianopolous(Director)Alex Morgan(Director)in

Co-investorsBison VenturesKairos Venture Investments, LlcKhosla VenturesScribble VenturesFortius VenturesMBX Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.